Your browser doesn't support javascript.
loading
Proinflammatory CD20+ T Cells are Differentially Affected by Multiple Sclerosis Therapeutics.
Quendt, Corinna; Ochs, Jasmin; Häusser-Kinzel, Silke; Häusler, Darius; Weber, Martin S.
  • Quendt C; Department of Neurology, University Medical Center, Göttingen, Germany.
  • Ochs J; Institute of Neuropathology, University Medical Center, Göttingen, Germany.
  • Häusser-Kinzel S; Institute of Neuropathology, University Medical Center, Göttingen, Germany.
  • Häusler D; Institute of Neuropathology, University Medical Center, Göttingen, Germany.
  • Weber MS; Department of Neurology, University Medical Center, Göttingen, Germany.
Ann Neurol ; 90(5): 834-839, 2021 11.
Article en En | MEDLINE | ID: mdl-34516013
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Subgrupos de Linfocitos T / Antígenos CD20 / Natalizumab / Esclerosis Múltiple Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Subgrupos de Linfocitos T / Antígenos CD20 / Natalizumab / Esclerosis Múltiple Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article